SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Alamos Gold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Al Collard who wrote (572)11/25/2001 9:48:24 AM
From: pull_da_trigger  Read Replies (1) of 4470
 
Hi Al,

I've heard people talking about "both contests" but didn't have this one bookmarked. Thanks for pointing it out.

Please put me down for 2941 long shares of ONC (closing ask $6.80).

Chart for Oncolytics Biotech:

stockcharts.com[l,a]djcanimy[dc][pc20!b50!b100!b200!f][vc60][iUb14!Ll14!La12,26,9!Lh14,3!Lc20]

The chart probably doesn't look the best, but it has been really low volume trading the last few weeks. I'd expect that a news release could come at any time indicating that their phase I trial has completed enrollment. Based on the volume/price move last June when some animal results got published, I'd say there are a lot of eyes on ONC, all waiting for phase I results.

Good luck,
P.D.T.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext